课题基金 / 基金详情

The OX40-OX40L molecule system in leukemia: Expression, function and modulation of NK cell reactivity

The OX40-OX40L molecule system in leukemia: Expression, function and modulation of NK cell reactivity
白血病中的 OX40-OX40L 分子系统:NK 细胞反应性的表达、功能和调节
批准号:
244459007
负责人:
Dr. Tina Nuebling
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2018-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
NK细胞在恶性肿瘤,尤其是白血病的免疫监测中发挥着重要作用。它们的反应性是由各种激活和抑制受体的信号平衡所引导的,而肿瘤坏死因子家族的几个成员也参与了这一过程。总的来说,肿瘤坏死因子家族的许多分子在肿瘤和免疫效应细胞的激活、增殖和凋亡中起着重要的作用。另有研究人员最近报道,NK细胞激活后可以表达肿瘤坏死因子家族成员OX40配体(OX40L),主要由抗原提呈细胞(APC)表达,在T细胞上充当OX40的配体。与肿瘤坏死因子家族的许多其他配体一样,OX40L能够双向传递信号,这种通过OX40L的反向信号被发现影响APC的免疫调节特性。OX40L在NK细胞上的功能作用以及它们与肿瘤细胞的相互作用尚不清楚。在该项目的前期工作中,我们发现,在癌症患者过继转移的临床应用中,由不同方案产生的多克隆NK细胞差异表达OX40L。通过OX40L进入NK细胞的信号导致NK细胞活化(CD69和NKp44上调),并增加NK细胞产生干扰素-γ。此外,我们已经制备了针对同源受体OX40的单抗,并对其进行了功能鉴定。使用这些抗体,我们可以证明OX40在患者白血病细胞上表达的百分比很高,主要是在AML中。OX40的刺激导致与病理生理相关的细胞因子的释放和白血病细胞代谢活性的增加。关于分子系统在NK细胞对恶性细胞的免疫监视中的功能相关性,进一步的初步数据显示,OX40-OX40L相互作用增加了NK细胞对靶细胞的反应性。拟议的项目现在旨在全面分析OX40在不同白血病实体患者样本中的表达,以及它作为疾病预后标志物的适用性。此外,我们计划研究OX40是否以及如何影响白血病细胞的增殖、凋亡、细胞因子的产生和免疫原性。最后,将深入研究OX40L对NK细胞反应性的影响,特别强调它在它们与恶性造血细胞相互作用中的作用。因此,该项目的总体目标是表征OX40及其配体在白血病细胞NK细胞免疫监测中的功能,以期对患者进行潜在的治疗调节。
英文摘要
NK cells play an important role in the immunosurveillance of malignancies, especially in leukemia. Their reactivity is guided by a balance of signals from a variety of activating and inhibitory receptors, and several members of the TNF family contribute to the same. In general, many molecules of the TNF family play an important role in the activation, proliferation, and apoptosis of both tumor and immune effector cells. Other investigators reported recently, that upon activation NK cells can express the TNF family member OX40 ligand (OX40L), which primarily is known to be expressed by antigen presenting cells (APC), where it serves as ligand for OX40 on T cells. Alike many other ligands of the TNF family, OX40L is capable to transduce bidirectional signals, and such reverse signaling via OX40L was found to affect the immunomodulatory properties of APC. The functional role of OX40L on NK cells in general and their interaction with tumor cells in particular is yet unknown. In the preliminary work for this project we found that polyklonal NK cells, generated by different protocols for clinical use in adoptive transfer to cancer patients, differentially express OX40L. Signaling via OX40L into NK cells led to activation (upregulation of CD69 and NKp44) and enhanced IFN-gamma production of the NK cells. Furthermore, we already generated and functionally characterized monoclonal antibodies against the cognate receptor OX40. Using these antibodies we could show that OX40 is expressed in a high percentage on patient leukemia cells, predominantly in AML. Stimulation of OX40 lead to release of pathophysiologically relevant cytokines and increased metabolic activity of the leukemia cells. With regard to the functional relevance of the molecule system in the immunosurveillance of malignant cells by NK cells, further preliminary data revealed that OX40-OX40L interaction increased the reactivity of NK cells against target cells.The proposed project now aims to comprehensively analyze the expression of OX40 in a larger cohort of samples from patients with various leukemia entities, and also its suitability as a prognostic marker in the disease. Furthermore we plan to study whether and how OX40 affects proliferation, apoptosis, cytokine production and immunogenicity of leukemia cells. Finally, the influence of OX40L on the reactivity of NK cells will be thoroughly examined with particular emphasis on its role in their interaction with malignant hematopoietic cells. The overall objective of this project thus is to characterize the function of OX40 and its ligand in NK cell immunosurveillance of leukemia cells with the aim of a potential therapeutic modulation in patients.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/2326-6066.cir-17-0212
发表时间: 2018-02-01
期刊: CANCER IMMUNOLOGY RESEARCH
影响因子: 10.1
作者: [Nuebling, Tina, Schumacher, Carla Emilia, Salih, Helmut Rainer]
通讯作者: Salih, Helmut Rainer
国内基金
海外基金
肾小管细胞OX40L调控Treg/Th17平衡在DN炎症损伤中的作用与机制
  • 批准号:
    2025JJ50604
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    肖力
  • 依托单位:
OX40/OX40L信号在胃肠间质瘤免疫微环境中作用机制及免疫策略研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    沈坤堂
  • 依托单位:
IL-25/DC/OX40L轴通过调控Tfh2细胞分化诱导嗜酸性鼻息肉局部IgE产生的作用和机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    孙悦奇
  • 依托单位:
OX40/OX40L介导中性粒细胞凋亡延迟在脓毒症致ARDS中的作用及其机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
  • 依托单位: